TI17 is a selective TRIP13 inhibitor with anticancer activity that inhibits the proliferation of multiple myeloma (MM) cells and induces cycle arrest and apoptosis in MM cells.
Molecular Weight:
374.43
Purity:
98.00%
CAS Number:
[1005178-02-8]
Formula:
C23H22N2O3
Target:
Apoptosis|||Thyroid hormone receptor(THR)
T87526
T87526
* VAT and and shipping costs not included. Errors and price changes excepted